Shanghai Junshi Biosciences soars on Hong Kong debut


HONG KONG: Chinese biotech startup Shanghai Junshi Biosciences Co Ltd soared more than 22% in its Hong Kong debut yesterday after raising US$394mil in its initial public offering (IPO), a rare strong showing by a biotech company in the Asian financial hub.

Shares of Junshi Biosciences opened at HK$23.50 (US$3) and closed at HK$23.7, about 22% above the IPO price of HK$19.38.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Junshi , IPO , Hong Kong

   

Next In Business News

Digital banks will not affect traditional banks in Malaysia
Dufu sees rise in global semiconductor sales and memory sector
MICCI, Penang work together to boost competitiveness in semiconductors, ports, trade
VSTECS appointed as the first Amazon Web Services distributor in Malaysia
Apple’s China iPhone shipments soar 12% in March after discounts
KLCI dips on profit taking, stays firmly above 1,600 level
Contentious content
Swedish central bank lowers key rate, sees two more cuts this year
Public Bank mobilises over RM53bil in sustainable finance
Stinky tofu tycoon a Changsha success story

Others Also Read